Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.

Cristina GurizzanLuigi LoriniAlberto PadernoMichele TomasoniGabriele ZiglianiAnna BozzolaLaura ArdighieriSimonetta BattocchioEliana BignottiAntonella RavaggiChiara RomaniLoris De CeccoMara Serena SerafiniRosalba MiceliElena BardelliniAlessandra MajoranaCesare PiazzaPaolo Bossi

Published in: BMC cancer (2021)

This trial was prospectively registered in ClinicalTrials.gov as NCT04504552 on 7th August 2020.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
placebo controlled